- Home
- GBIO vs STEC Comparison
GBIO vs STEC Comparison
Compare GBIO & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- STEC
- Stock Information
- Founded
- GBIO 2016
- STEC 2006
- Country
- GBIO United States
- STEC Hong Kong
- Employees
- GBIO N/A
- STEC N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- GBIO Health Care
- STEC
- Exchange
- GBIO Nasdaq
- STEC NYSE
- Market Cap
- GBIO 29.5M
- STEC 63.8M
- IPO Year
- GBIO 2020
- STEC 2021
- Fundamental
- Price
- GBIO $4.39
- STEC $0.72
- Analyst Decision
- GBIO Strong Buy
- STEC
- Analyst Count
- GBIO 4
- STEC 0
- Target Price
- GBIO $73.33
- STEC N/A
- AVG Volume (30 Days)
- GBIO 210.2K
- STEC 12.8K
- Earning Date
- GBIO 08-06-2025
- STEC 08-05-2025
- Dividend Yield
- GBIO N/A
- STEC N/A
- EPS Growth
- GBIO N/A
- STEC N/A
- EPS
- GBIO N/A
- STEC N/A
- Revenue
- GBIO $24,556,000.00
- STEC $10,672,000.00
- Revenue This Year
- GBIO N/A
- STEC $9,392.20
- Revenue Next Year
- GBIO N/A
- STEC N/A
- P/E Ratio
- GBIO N/A
- STEC N/A
- Revenue Growth
- GBIO 146.47
- STEC N/A
- 52 Week Low
- GBIO $3.00
- STEC $0.20
- 52 Week High
- GBIO $35.80
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- GBIO 53.21
- STEC 38.03
- Support Level
- GBIO $4.28
- STEC $0.70
- Resistance Level
- GBIO $5.10
- STEC $0.80
- Average True Range (ATR)
- GBIO 0.62
- STEC 0.08
- MACD
- GBIO 0.01
- STEC 0.00
- Stochastic Oscillator
- GBIO 30.16
- STEC 34.03
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.